| Annual Financials | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 61 | 57 | 69 | 79 | 83 | 0 |
| Expenses | 54 | 57 | 56 | 60 | 71 | 0 |
| EBITDA | 6 | -1 | 13 | 19 | 13 | 0 |
| Operating Profit % | 10 % | -2 % | 16 % | 23 % | 15 % | 0 % |
| Depreciation | 4 | 4 | 4 | 4 | 5 | 0 |
| Interest | 2 | 1 | 2 | 2 | 2 | 0 |
| Profit Before Tax | 1 | -6 | 7 | 13 | 6 | 0 |
| Tax | 3 | -0 | 1 | 4 | 2 | 0 |
| Net Profit | -2 | -6 | 6 | 9 | 4 | 0 |
| EPS in ₹ | -1.32 | -5.21 | 5.27 | 8.15 | 3.48 | 0.00 |
Modern Diagnostic & Research Centre
Modern Diagnostic & Research Centre
60.84
+10.14
(20.00%)
Market Cap
91.92 Cr
PE Ratio
-
Volume
86,400.00
Day High - Low
60.84 - 49.00
52W High-Low
100.00 - 45.00
Key Fundamentals
Market Cap
91.92 Cr
EPS
3.48
PE Ratio
-
PB Ratio
1.33
Book Value
38.16
EBITDA
12.59
Dividend Yield
0.00 %
Industry
Healthcare Sector
Healthcare Service Provider Return on Equity
43.27
Debt to Equity
1.31
Actual
Company News
View All News
Modern Diagnostic & Research Centre Ltd has appointed M/s. Kuldeep Bisht & Associates as the scrutinizer for its upcoming 14th Annual General Meeting, ensuring compliance with SEBI LODR regulations.
Modern Diagnostic Board Meeting Set for Sep 3
Aug 26, 2026
Aug 26, 2026Modern Diagnostic & Research Centre Ltd has scheduled a board meeting for September 3, 2026. The agenda includes approving the AGM notice, director report, and scrutinizer appointment.
Modern Diagnostic FY26 net profit falls 42%May 29, 2026
May 29, 2026Modern Diagnostic reported a 42% decline in FY26 net profit to ₹525.33 lakh, while revenue rose 7% to ₹8,311.06 lakh. The company listed on BSE SME in January 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,919.70 | #1 32,181.42 | 58.73 | #1 2,864.20 | 12.11 | #1 510 | 27.24 | 56.09 | |
1,498.90 | 15,423.19 | 82.60 | 835.00 | 19.34 | 173 | 37.56 | 57.68 | |
602.10 | 12,483.20 | 59.48 | 1,671.40 | 24.15 | 191 | 25.61 | 63.40 | |
566.85 | 9,022.29 | 51.50 | 846.00 | 20.48 | 163 | 33.94 | 44.00 | |
733.45 | 7,359.49 | 87.83 | 1,023.40 | 32.93 | 77 | 35.02 | 61.85 | |
560.95 | 1,819.65 | 18.21 | 772.77 | 4.05 | 106 | -19.51 | 52.24 | |
335.65 | 1,748.09 | 50.51 | 313.60 | 22.55 | 31 | 40.22 | 64.76 | |
1,476.10 | 1,266.89 | 22.23 | 141.92 | 27.17 | 61 | -28.57 | 63.98 | |
541.00 | 1,057.28 | #1 14.09 | 498.18 | #1 237.06 | 69 | #1 45.92 | 45.30 | |
299.50 | 952.72 | -36.95 | 1,319.27 | 12.68 | -3 | -92.48 | 48.91 |
Growth Rate
Revenue Growth
5.47 %
Net Income Growth
-54.33 %
Cash Flow Change
73.14 %
ROE
-12.20 %
ROCE
31.49 %
EBITDA Margin (Avg.)
-37.35 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 49 | 37 | 50 | 65 | 119 |
| Fixed Assets | 24 | 24 | 27 | 31 | 58 |
| Current Assets | 18 | 12 | 18 | 24 | 43 |
| Capital Work in Progress | 1 | 0 | 4 | 9 | 10 |
| Investments | 0 | 0 | 0 | 0 | 7 |
| Other Assets | 24 | 13 | 19 | 25 | 0 |
| Total Equity & Liabilities | 49 | 37 | 50 | 65 | 119 |
| Current Liabilities | 21 | 21 | 24 | 32 | 44 |
| Non Current Liabilities | 17 | 9 | 14 | 12 | 16 |
| Total Equity | 12 | 6 | 12 | 21 | 59 |
| Reserve & Surplus | 11 | 5 | 11 | 10 | 44 |
| Share Capital | 1 | 1 | 1 | 11 | 15 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 3 | -5 | 0 | 0 |
| Investing Activities | -5 | 2 | -11 | -13 |
| Operating Activities | 4 | -0 | 8 | 14 |
| Financing Activities | 5 | -7 | 3 | -0 |
Share Holding
| % Holding | Dec 1899 | Mar 2025 | Dec 2025 | Jan 2026 | Mar 2026 |
| Promoter | 72.85 % | 100.00 % | 100.00 % | 72.85 % | 72.85 % |
| FIIs | 1.07 % | 0.00 % | 0.00 % | 1.07 % | 0.03 % |
| DIIs | 11.80 % | 0.00 % | 0.00 % | 11.80 % | 15.48 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 12.82 % | 0.00 % | 0.00 % | 12.82 % | 4.75 % |
| Others | 1.46 % | 0.00 % | 0.00 % | 1.45 % | 6.89 % |
| No of Share Holders | 641 | 7 | 7 | 641 | 282 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Sept 2026 |  Annual General Meeting | NA | 30 Sept 2026 | 48.51 | 50.70 |
| 29 May 2026 |  Quarterly Result Announcement | NA | 29 May 2026 | 72.05 | 71.00 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
3 days agoReg. 34 (1) Annual Report.4 days ago
4 days agoRevised Letter Attached In The Intimation For 14Th AGM Of The Company4 days ago
4 days agoRevised Date In The Letter Attached For Intimation Of Book Closure4 days ago
4 days agoRevised Date In The Letter Attached For Intimation Of Record Date4 days ago
4 days agoIntimation For The 14Th Annual General Meeting (AGM) And Book Closure6 days ago
6 days agoIntimation For The 14Th Annual General Meeting (AGM) And Book Closure6 days ago
6 days agoIntimation For Record Date6 days ago
6 days agoIntimation Of Appointment Of Scrutinizer Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (LODR)6 days ago
6 days agoBoard Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20156 days ago
6 days agoBoard Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 26, 2026
Aug 26, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Aug 10, 2026
Aug 10, 2026Financial Results For The Half Year And Year Ended 31.03.2026May 29, 2026
May 29, 2026Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 29, 2026
May 29, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2026
May 28, 2026Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations 2015May 21, 2026
May 21, 2026Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Year Ended 31St March 2026May 21, 2026
May 21, 2026Disclosure Under Regulation 41(4) Of SEBI (Issue Of Capital And Disclosure Requirements) Regulations 2018 For The Year Ended 31St March 2026May 15, 2026
May 15, 2026Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 13, 2026
May 13, 2026Board Meeting Intimation for Intimation Of Board MeetingMay 12, 2026
May 12, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018May 02, 2026
May 02, 2026Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Apr 16, 2026
Apr 16, 2026Clarification sought from Modern Diagnostic & Research Centre LtdApr 08, 2026
Apr 08, 2026Closure of Trading WindowMar 30, 2026
Mar 30, 2026Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 09, 2026
Mar 09, 2026Board Meeting Intimation for Notice Is Hereby Given That Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Monday 09Th Day Of March 2026 At 01:00 PM At 363/4 Jawahar Nagar New Railway Road Gurugram- 122001
Feb 28, 2026
Feb 28, 2026Listing of Equity Shares of Modern Diagnostic & Research Centre LtdJan 07, 2026
Jan 07, 2026Technical Indicators
RSI(14)
Neutral 49.74
ATR(14)
Less Volatile 2.66
STOCH(9,6)
Neutral 22.94
STOCH RSI(14)
Neutral 28.52
MACD(12,26)
Bearish -0.01
ADX(14)
Weak Trend 10.61
UO(9)
Bearish 44.91
ROC(12)
Downtrend And Accelerating -0.59
WillR(14)
Neutral -52.50
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
